SCHEMBL7513856

SCHEMBL7513856

O=C(O)Oc1ccc2cncnc2c1

nearest known ligand 0.61

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
EGFR P00533 7/20 0.61
IMPDH2 P12268 2/20 0.43
NOTUM Q6P988 1/20 0.41
BAZ1A Q9NRL2 1/20 0.40
HPGDS O60760 6/20 0.39
PRMT3 O60678 1/20 0.38
ALDH1A1 P00352 1/20 0.37
F2 P00734 1/20 0.37
GLA P06280 1/20 0.37
HPGD P15428 1/20 0.37
HDAC1 Q13547 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
HDAC5 Q9UQL6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27630991 0.89 EGFR (0.64) EGFRIMPDH2NOTUMHPGDSALDH1A1
SCHEMBL3942891 0.87 EGFR (0.61) EGFRBAZ1AALDH1A1F2GLA
SCHEMBL6825418 0.86 EGFR (0.59) EGFRIMPDH2NOTUMBAZ1AHPGDS
SCHEMBL8520119 0.83 EGFR (0.65) EGFRIMPDH2NOTUMBAZ1AHPGDS
SCHEMBL13837704 0.79 EGFR (0.73) EGFRIMPDH2NOTUMBAZ1AHPGDS
SCHEMBL535665 0.76 EGFR (0.64) EGFRALDH1A1F2GLAHPGD
SCHEMBL668493 0.76 EGFR (1.00) EGFRHPGDSALDH1A1
SCHEMBL30241125 0.76 EGFR (1.00) EGFRHPGDSALDH1A1
SCHEMBL29517021 0.76 EGFR (1.00) EGFRHPGDSALDH1A1
SCHEMBL933273 0.75 CYP3A4 (0.56) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1228060-A1 ARYLALKANE, ARYLALKENE AND ARYL AZAALKANE, MEDICAMENTS CONTAINING SAID COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF Boehringer Ingelheim Pharma KG (DE) 2002-08-07 EP disclosed
WO-2001032649-A1 ARYLALKANE, ARYLALKENE AND ARYL AZAALKANE, MEDICAMENTS CONTAINING SAID COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-05-10 WO disclosed